title: Flare up of symptoms after discontinuation of sunitinib in patient with lung cancer.
authors.forename: Wanfeng
authors.initials: W
authors.lastname: Guo
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Liu
authors.forename: Hongjun
authors.initials: H
authors.lastname: Gao
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology* / Q000628:therapy; D000077192:Adenocarcinoma of Lung; D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D003131:Combined Modality Therapy; D018450:Disease Progression; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011758:Pyrroles / Q000008:administration & dosage*; D000077210:Sunitinib; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib